Intensive speech treatment for patients with Parkinson's disease: short-and long-term comparison of two techniques. 1996

L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
Department of Communication Disorders and Speech Science, University of Colorado-Boulder, Wilbur James Gould Voice Research Center, Denver Center for the Performing Arts, CO, USA.

The purpose of this study was to evaluate the long-term (12 months) effects of two forms of speech treatment on the speech and voice deficits that occur in Parkinson's disease. Thirty-five patients with idiopathic Parkinson's disease were assigned to one of two speech treatment groups: voice and respiration (The Lee Silverman Voice Treatment [LSVT]) or placebo (respiration) treatment. Vocal intensity data from before, immediately after, and at 6 and 12 months after speech treatment revealed statistically significant differences between the treatment groups. Only subjects in the LSVT group improved or maintained vocal intensity above pretreatment levels by 12 months after treatment. The placebo group had statistically significant deterioration of vocal intensity levels from before to 12 months after treatment during conversational monologue. The LSVT group did not deteriorate to levels below pretreatment in vocal intensity over the 12-month period. This study is the first to document the short-and long-term effects of intensive speech treatment (LSVT), which focuses on the voice, for patients with Parkinson's disease compared with a placebo speech treatment group.

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009483 Neuropsychological Tests Tests designed to assess neurological function associated with certain behaviors. They are used in diagnosing brain dysfunction or damage and central nervous system disorders or injury. Aphasia Tests,Cognitive Test,Cognitive Testing,Cognitive Tests,Memory for Designs Test,Neuropsychological Testing,AX-CPT,Behavioral Assessment of Dysexecutive Syndrome,CANTAB,Cambridge Neuropsychological Test Automated Battery,Clock Test,Cognitive Function Scanner,Continuous Performance Task,Controlled Oral Word Association Test,Delis-Kaplan Executive Function System,Developmental Neuropsychological Assessment,Hooper Visual Organization Test,NEPSY,Neuropsychologic Tests,Neuropsychological Test,Paced Auditory Serial Addition Test,Repeatable Battery for the Assessment of Neuropsychological Status,Rey-Osterrieth Complex Figure,Symbol Digit Modalities Test,Test of Everyday Attention,Test, Neuropsychological,Tests, Neuropsychological,Tower of London Test,Neuropsychologic Test,Test, Cognitive,Testing, Cognitive,Testing, Neuropsychological,Tests, Cognitive
D010300 Parkinson Disease A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75) Idiopathic Parkinson Disease,Lewy Body Parkinson Disease,Paralysis Agitans,Primary Parkinsonism,Idiopathic Parkinson's Disease,Lewy Body Parkinson's Disease,Parkinson Disease, Idiopathic,Parkinson's Disease,Parkinson's Disease, Idiopathic,Parkinson's Disease, Lewy Body,Parkinsonism, Primary
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D013064 Speech Disorders Acquired or developmental conditions marked by an impaired ability to comprehend or generate spoken forms of language. Aprosodia,Aprosodic Speech,Cluttering,Dysglossia,Dyslalia,Rhinolalia,Verbal Fluency Disorders,Aprosodias,Clutterings,Dysglossias,Dyslalias,Rhinolalias,Speech, Aprosodic,Verbal Fluency Disorder
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
August 2012, The Cochrane database of systematic reviews,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
December 1984, The British journal of disorders of communication,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
November 2021, Brain sciences,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
February 2022, EClinicalMedicine,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
January 2001, The Cochrane database of systematic reviews,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
January 2001, The Cochrane database of systematic reviews,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
January 2001, The Cochrane database of systematic reviews,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
April 2007, CNS spectrums,
L O Ramig, and S Countryman, and C O'Brien, and M Hoehn, and L Thompson
January 1988, Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists,
Copied contents to your clipboard!